You can add Maine to the growing list of states that have passed a law seeking more transparency about prescription drug pricing.
However, unlike a few states that quickly required drug makers to provide cost and pricing information about their medicines – California, Vermont, Nevada, and Oregon — Maine is taking a two-step approach.
About the Author Reprints
This line struck me – “passing legislation to lower drug costs should be a “top priority” for President Trump, who is expected to deliver a speech about the issue.”
I thought the President’s objection to the last administration was ‘all talk and no action’ – the tradition continues, it would seem. (And wasn’t said speech due last week?)
please send me the information